LSPN 19: AI ‘explosion’ and drug costs in Canada
17-10-2019
LSPN 19: Courts need to revisit patentability of diagnostic tests
26-04-2019
Viktoria Kurpas / Shutterstock.com
In the fast-paced environment of life sciences, the need for the IP sector to take full advantage of potential and emerging innovations is paramount, as a LSPN Connect session discovered.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
LSPN, inventions, life sciences, innovation, patents, COVID-19, trade secrets, confidentiality, R&D, IP education, harvesting, technology
